Larger Relationship Between Diabetes and Alzheimer Disease and Related Dementias (ADRD)
Journal of Health Care and Research · 06.03.2026 · 1
DOI: 10.36502/2026/droa.6196 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Health Care and Research, online erschienen am 06.03.2026. Verfasst von Hiroshi Bando und 3 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz, Diabetes mellitus
Abstract (Originalsprache)
Patients with Alzheimer disease and related dementias (ADRD) tend to develop diabetes more than those without diabetes. Diabetic treatments mainly include DPP4-i, GLP-1RAs, and SGLT2-i. They are reported to decrease neuroinflammation, amyloid beta accumulation, and hyperphosphorylation of tau protein, and to prevent neuronal loss and enhance neurogenesis. Anti-diabetic agents may decrease dementia risk in T2D based on large research data of 4 million individuals. As a result, the odds ratios (OR) for reducing dementia showed SGLT2-i 0.69, GLP-1RA 0.70, DPP4-i 0.86, metformin 0.92, sulfonylurea 1.02, α-GI 1.14, and insulin 1.26. From some studies, GLP-1RAs and SGLT2-i show a similar degree of clinical effect.
Zitieren
APA
Bando, H., Urasaki, H., Bando, M., & Yoshioka, A. (2026). Larger Relationship Between Diabetes and Alzheimer Disease and Related Dementias (ADRD). Journal of Health Care and Research, 1. https://doi.org/10.36502/2026/droa.6196
Vancouver
Bando H, Urasaki H, Bando M, Yoshioka A. Larger Relationship Between Diabetes and Alzheimer Disease and Related Dementias (ADRD). Journal of Health Care and Research. 2026:1. doi:10.36502/2026/droa.6196
BibTeX
@article{Bando2026,
author = {Bando, Hiroshi and Urasaki, Hirohisa and Bando, Masahiro and Yoshioka, Akiyo},
title = {Larger Relationship Between Diabetes and Alzheimer Disease and Related Dementias (ADRD)},
journal = {Journal of Health Care and Research},
year = {2026},
pages = {1},
doi = {10.36502/2026/droa.6196}
}
EUVIMED